01
The expensive sequence starts with an undefined question
Sending an entire chart to an expert without a focused issue can force highly specialized time into basic orientation. The expert must identify the relevant period, sort duplicate records, locate missing material, and infer what counsel wants reviewed before reaching the substantive question.
That approach may be necessary in some matters, but it should not be automatic. Screening Intelligence creates a narrower first pass: define the target event, reconstruct the critical sequence, identify obvious limitations, and determine which questions appear to justify deeper investigation.
02
What responsible screening should produce
A screening deliverable should be explicit about its scope and limits. It should distinguish documented events from preliminary review observations and reserve ultimate opinions for the qualified expert and counsel.
- A focused timeline around the target clinical issue
- Preliminary issue flags tied to the record
- A missing-record request list
- Documentation conflicts or timing questions
- Focused questions for the appropriate expert specialty
- A clear statement of what the screening does not decide
03
Screening can also reveal that the record is not ready
Sometimes the most useful conclusion is that the available production cannot responsibly support the requested review. Missing medication records, outside-facility documents, monitor data, or procedure notes may prevent reliable sequencing.
That is not a failed screening. It is decision intelligence. Counsel can request the missing material before paying for a deeper analysis that would later need to be repeated.
04
The boundary matters
Critical Timeline’s Attorney Case Screening identifies clinically significant issues and questions that may warrant expert attention. It does not determine case merit, negligence, liability, causation, damages, or value.
The honest promise is not that screening will make every case cheaper or stronger. It is that counsel receives a more organized medical question before making the next investment.
